Johnson & Johnson Private Limited
Clinical trials sponsored by Johnson & Johnson Private Limited, explained in plain language.
-
New hope for Tough-to-Treat blood cancer patients in india
Disease control Recruiting nowThis study is checking the safety of the drug teclistamab when used in real-world hospital settings in India. It involves 75 adults with advanced multiple myeloma, a blood cancer that has returned or stopped responding after at least three previous treatments. The main goal is to…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Apr 04, 2026 03:51 UTC
-
New hope for indian patients with stubborn arthritis
Disease control Recruiting nowThis study is testing how safe and effective the drug guselkumab is for Indian patients with psoriatic arthritis, a painful autoimmune condition that affects the joints and skin. It is for people whose symptoms have not improved enough with standard medications. Researchers will …
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC